Louisiana carries one of the highest obesity rates in the country (around 36 to 38 percent of adults), and the combination of hot humid weather, hurricane season, and a deeply food-centered French and Creole culture creates a distinct GLP-1 landscape. This 2026 guide explains where Louisiana residents in New Orleans, Baton Rouge, Lafayette, Shreveport, and the rural parishes can access semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) through telehealth, what Healthy Louisiana covers, how Ochsner Health structures obesity medicine, and how to keep continuity of care when a tropical storm threatens the Gulf.

Key Takeaways for Louisiana Patients

All major GLP-1 telehealth platforms (Hims, Ro, Hers, Henry Meds, Remedy Meds, Mochi Health) ship to Louisiana addresses and prescribe through Louisiana-licensed clinicians.
Healthy Louisiana covers branded GLP-1s for type 2 diabetes (Ozempic, Mounjaro, Trulicity) but anti-obesity coverage (Wegovy, Zepbound) requires prior authorization with strict BMI and comorbidity criteria.
Ochsner Health operates the largest obesity medicine and bariatric program in the state, with locations across Greater New Orleans, Baton Rouge, and the Northshore.
Hurricane preparation matters: Louisiana patients should keep a 30 to 60 day supply on hand from May through November and request early refills before a named storm enters the Gulf.
Compounded semaglutide remains available only under FDA personalization rules after the 2024 to 2025 shortage resolution; many telehealth brands have transitioned Louisiana patients to branded products.

Best Telehealth GLP-1 Providers Serving Louisiana

Louisiana participates in the Interstate Medical Licensure Compact (IMLC), so nearly every national telehealth platform can quickly onboard prescribers licensed in the state through the Louisiana State Board of Medical Examiners. The six services below all ship to Louisiana addresses in 2026.

1. Hims Weight Loss (Louisiana)

Hims offers oral metabolic support and compounded or branded GLP-1 options through partner pharmacies. Louisiana patients complete an asynchronous intake reviewed by a state-licensed clinician, typically within 24 hours. Shipping to New Orleans, Baton Rouge, and Shreveport addresses generally arrives within two to three business days.

Check Hims Pricing in Louisiana

2. Ro Body Program

Ro pairs branded Wegovy and Zepbound prescriptions (when medically appropriate) with a coaching app, scale, and nurse messaging. Ro accepts most Louisiana commercial plans for branded coverage and offers a cash-pay path when Healthy Louisiana or BCBS LA declines the prior authorization.

Start Ro in Louisiana

3. Hers Weight Loss

Hers focuses on women’s metabolic care, popular with patients in the New Orleans, Lafayette, and Baton Rouge markets seeking provider continuity through telehealth. Hers includes hormonal and PCOS considerations in the intake, which is relevant for many South Louisiana women.

Try Hers in Louisiana

4. Henry Meds

Henry Meds operates a flat-rate compounded semaglutide and tirzepatide model where available under personalization rules. Louisiana patients receive shipments from FDA-registered 503A pharmacies; cold-chain packaging is calibrated for Gulf Coast summer temperatures.

View Henry Meds Plans

5. Remedy Meds

Remedy Meds bundles GLP-1 therapy with metabolic labs and unlimited provider messaging. Pricing in Louisiana is identical to other Gulf states, and the platform schedules shipments around forecasted hurricane landfall when patients flag travel or evacuation.

Compare Remedy Meds

6. Mochi Health

Mochi Health emphasizes obesity-medicine board-certified clinicians and insurance navigation. For Louisiana patients with employer coverage through BCBS LA, Vantage, or Humana, Mochi will attempt branded prior authorization before defaulting to a cash-pay or compounded path.

See Mochi Health Pricing

GLP-1 Pricing in Louisiana (2026)

Cash pricing in Louisiana tracks national averages, though Rouses, Winn-Dixie, and independent Cajun-country pharmacies frequently honor manufacturer copay cards more flexibly than chain mail-order systems. Expect the following ranges:

Wegovy (semaglutide): $1,250 to $1,450 per month cash; $0 to $25 per month with commercial insurance plus Novo Nordisk savings card.
Zepbound (tirzepatide): $1,050 to $1,300 per month cash; LillyDirect self-pay vials at $349 to $699 depending on dose.
Ozempic and Mounjaro: typically $950 to $1,100 cash; copay cards drop insured patients to $25.
Compounded semaglutide via telehealth: $199 to $399 per month, depending on dose and platform.

Louisiana pharmacy tips: Rouses Markets pharmacies in Acadiana and the Northshore stock GLP-1s reliably and often have shorter wait times than chain stores in New Orleans. Winn-Dixie and Walgreens dominate metro markets, while CVS Caremark processes the majority of Louisiana employer-sponsored PBM claims.

Healthy Louisiana Medicaid and GLP-1 Coverage

Healthy Louisiana (administered through five managed care organizations: Aetna Better Health, AmeriHealth Caritas, Healthy Blue, Louisiana Healthcare Connections, and United Healthcare Community Plan) follows a single Preferred Drug List (PDL) maintained by the Louisiana Department of Health.

Diabetes GLP-1s (Ozempic, Mounjaro, Trulicity, Victoza): covered with prior authorization confirming T2DM diagnosis and metformin trial.
Anti-obesity GLP-1s (Wegovy, Zepbound, Saxenda): covered with prior authorization requiring BMI of 30 or higher (or 27+ with a qualifying comorbidity such as hypertension, dyslipidemia, sleep apnea, or cardiovascular disease), documented lifestyle program participation, and step therapy through phentermine or other older agents.
Compounded GLP-1s: not covered by Healthy Louisiana.

If a prior authorization is denied, Louisiana patients have 30 days to appeal through their MCO and an additional state-level Fair Hearing right through the Department of Health.

Major Louisiana Obesity-Medicine Systems

Ochsner Health

Ochsner is the dominant integrated health system in Louisiana, with the Ochsner Medical Center on Jefferson Highway in New Orleans serving as the hub. The Ochsner Bariatric and Metabolic Health program offers medical weight management, GLP-1 prescribing, and surgical pathways (sleeve gastrectomy, gastric bypass, SADI-S). Ochsner accepts Healthy Louisiana, Medicare, and most Louisiana commercial plans.

LSU Health Sciences and Tulane Medical

LSU Health New Orleans and LSU Health Shreveport operate academic obesity medicine clinics that frequently enroll patients in GLP-1 and metabolic surgery research. Tulane Medical’s bariatric program in Uptown New Orleans rounds out the academic options.

Our Lady of the Lake (Baton Rouge)

Our Lady of the Lake Regional Medical Center anchors obesity-medicine and bariatric services for the Capital Region with multidisciplinary teams including registered dietitians and behavioral health support.

Compounded GLP-1 Rules in Louisiana

The Louisiana Board of Pharmacy regulates 503A and 503B compounders under federal FDA guidance. After the FDA declared the semaglutide and tirzepatide shortages resolved in 2025, compounded versions are only legally dispensed when:

A prescriber documents a clinical reason for personalization (allergy to an inactive ingredient, dose not commercially available, combination with B12 or other adjunct).
The compounding pharmacy is registered with the Louisiana Board of Pharmacy or with the FDA as a 503B outsourcing facility.
The product is dispensed pursuant to a valid patient-specific prescription.

Patients receiving compounded products by mail from out-of-state pharmacies should verify the pharmacy’s Louisiana non-resident pharmacy permit.

Telehealth Prescribing Rules in Louisiana

The Louisiana State Board of Medical Examiners requires that prescribers be Louisiana-licensed (or operating under a compact privilege) and that the patient have a documented evaluation – audio-video or, in most cases, asynchronous review with appropriate history and labs – before a prescription is issued. GLP-1s are non-controlled, so Louisiana does not require an in-person visit before prescribing. A follow-up visit is required at least every 90 days while on therapy.

Climate and Regional Considerations

Heat, Humidity, and Hydration

Louisiana’s heat index frequently exceeds 105 degrees from May through September. GLP-1s reduce thirst signaling and slow gastric emptying, which compounds dehydration risk. Patients should aim for 80 to 100 ounces of water daily, supplement electrolytes during outdoor work (lawn care, festivals, fishing), and monitor for dizziness or constipation.

Hurricane Season and Medication Supply

From June 1 through November 30, Louisiana patients should:

Keep a 30-day GLP-1 buffer in a working refrigerator, with a backup cooler and ice plan.
Request early refills when a named storm enters the Gulf – most Louisiana insurers waive refill-too-soon restrictions during a declared state of emergency.
Carry a printed prescription record and a small cooler when evacuating.
Confirm that telehealth providers can ship to a temporary out-of-state evacuation address.

French and Creole Food Culture

South Louisiana cuisine is calorie-dense (gumbo, etouffee, jambalaya, beignets, po-boys). Successful GLP-1 patients in the region typically work with a registered dietitian to maintain cultural foods in smaller portions rather than eliminate them, often emphasizing seafood, okra, and traditional one-pot dishes with lean protein.

Cost-Saving Paths for Louisiana Patients

Manufacturer savings cards: Novo Nordisk (Wegovy, Ozempic) and Eli Lilly (Zepbound, Mounjaro) savings programs cap commercial copays at $25 per month.
LillyDirect self-pay vials: Zepbound vials at $349 to $699 ship directly to Louisiana addresses.
Patient assistance: Novo Nordisk PAP and Lilly Cares cover qualifying low-income uninsured Louisiana patients at no cost.
Telehealth cash plans: Hims, Henry Meds, Remedy Meds, and Mochi offer $199 to $399 monthly compounded paths where clinically justified.
HSA/FSA: GLP-1 therapy for an obesity diagnosis is HSA/FSA eligible.

Louisiana-Specific FAQ

1. Can I get a GLP-1 prescription in Louisiana without ever visiting a clinic?

Yes. Louisiana permits telehealth-only prescribing of non-controlled medications including GLP-1s. The clinician must be Louisiana-licensed and perform an appropriate evaluation, but no in-person visit is required.

2. Does Healthy Louisiana cover Wegovy or Zepbound?

Yes, with prior authorization requiring BMI of 30+ (or 27+ with comorbidity), documented lifestyle program participation, and step therapy. Approval rates have improved through 2025 and 2026 as the program updates its PDL.

3. What if a hurricane disrupts my Ochsner appointment or shipment?

Louisiana insurers typically waive refill restrictions during a declared state of emergency. Ochsner offers MyOchsner virtual visits for established patients, and telehealth platforms reroute shipments to evacuation addresses on request.

4. Is compounded semaglutide still legal in Louisiana in 2026?

Yes, when prescribed for a documented clinical reason (allergy, dose customization, adjunct combination) and dispensed by a Louisiana-permitted pharmacy. Mass-marketed compounded GLP-1 without personalization may face enforcement.

5. Which Louisiana pharmacy chain is best for GLP-1 fills?

Rouses and Winn-Dixie typically have shorter waits than CVS or Walgreens in metro New Orleans. For consistent stocking across the state, Walgreens has the broadest footprint, and Costco offers competitive cash pricing in Baton Rouge, Metairie, and Covington.

6. Do Ochsner and BCBS Louisiana cover GLP-1s for obesity?

BCBS Louisiana commercial plans cover Wegovy and Zepbound with prior authorization on most employer formularies. Ochsner Health Plan follows the same standard. Self-funded employer carve-outs vary – check with HR.

7. How does Louisiana heat affect my injection storage?

Branded GLP-1 pens are stable at room temperature (below 86 F) for up to 28 days after first use. In a Louisiana summer power outage, move pens to an insulated cooler with ice packs; do not freeze. Discard pens exposed to temperatures above 86 F for prolonged periods.

8. Can I get a GLP-1 in rural Acadiana or North Louisiana?

Yes. Telehealth is the most efficient option for residents far from Ochsner or LSU clinics. All six platforms listed above ship to Louisiana ZIP codes, and pickup can be arranged at local independent pharmacies in places like Opelousas, Natchitoches, Ruston, or Monroe.

Disclaimer and Safety Information

Medical disclaimer: This guide is educational and is not medical advice. GLP-1 receptor agonists are prescription medications that should only be used under the supervision of a licensed clinician.

Important contraindications for semaglutide and tirzepatide:

Personal or family history of medullary thyroid carcinoma (MTC).
Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
History of pancreatitis (relative contraindication; discuss with prescriber).
Pregnancy or active attempts to conceive.
Severe gastroparesis or inflammatory bowel disease.

Common side effects: nausea, vomiting, diarrhea, constipation, fatigue, and injection-site reactions. Rare but serious risks include pancreatitis, gallbladder disease, kidney injury from dehydration, and severe hypoglycemia (when combined with insulin or sulfonylureas).

Affiliate disclosure: BestMDHub may receive a commission when you sign up through telehealth links on this page. Commission does not affect editorial rankings or clinical recommendations.

Sources

Louisiana Department of Health – Healthy Louisiana Preferred Drug List, 2026 edition.
Louisiana State Board of Medical Examiners – Telehealth Practice Standards.
Louisiana Board of Pharmacy – Compounding Rules, Title 46 Part LIII.
Ochsner Health – Bariatric and Metabolic Health program materials.
FDA Drug Shortage Database, 2025 to 2026 updates.
Novo Nordisk and Eli Lilly product labels and patient assistance program documentation.
CDC Behavioral Risk Factor Surveillance System (BRFSS) – Louisiana obesity prevalence data.